Basic Anafranil Information

• INN (International Nonproprietary Name): Clomipramine.
• Brand Names Available In Australia: Anafranil, Clopram, Clofranil (brand variants and local packaging may vary; check with your pharmacy).
• ATC Code: N06AA04 (Antidepressants, tricyclic — Clomipramine).
• Forms & Dosages: Capsules and tablets commonly available in 10 mg (varies), 25 mg, 50 mg and 75 mg for oral administration.
• Manufacturers In Australia: Originator and global supplier listed as Novartis Pharma AG (via Sandoz) with other international suppliers including Sun Pharma, Zydus, Torrent, Teva and Sanofi; local availability depends on pharmacy stock.
• Registration Status In Australia: Prescription-only medication (Rx) with listings for obsessive–compulsive disorder; availability and registered indications may vary by product — check local listings.
• OTC / Rx Classification: Prescription-only medication (Rx) in all countries surveyed; not available over the counter.

Key Findings From Recent Trials

Worried whether Anafranil still works for hard-to-treat OCD?

Recent systematic reviews and meta-analyses from 2022–2024 reaffirm clomipramine’s robust efficacy in obsessive–compulsive disorder compared with placebo and show advantages in some analyses versus SSRIs for treatment-resistant cases.

Australian cohort and specialist clinic series from 2022–2023 report clomipramine remains a go-to second-line or adjunct option after SSRI failure, especially in severe, refractory presentations.

Outcomes in these datasets include higher response rates in treatment-resistant cohorts and faster reductions in compulsive rituals for some patients.

Trials also show particular benefit in serotonergic-resistant presentations where strong SERT blockade can restore clinical response.

TGA and international pharmacovigilance reports emphasise a higher anticholinergic burden and cardiac conduction risks as important safety signals.

Australian TGA case reviews between 2022 and 2024 flagged orthostatic hypotension and tachyarrhythmia risk in older adults with comorbidities.

An emerging 2024–25 trend is renewed interest in personalised dosing using therapeutic drug monitoring and ECG-based risk stratification to improve tolerability.

Evidence quality is mixed: several small RCTs plus larger observational datasets, so clinicians commonly balance efficacy against tolerability in practice.

Practice takeaway: clomipramine is evidence-backed for refractory OCD but requires structured monitoring when used.

Major 2022–2025 Australian & Global Studies

Main Outcomes

What did clinics and trials actually record as benefits?

Multiple recent analyses show improved response rates for clomipramine in treatment-resistant OCD compared with placebo and in head-to-head comparisons in selected groups versus SSRIs.

Specialist clinic series reported quicker reductions in compulsive rituals for some patients, leading to improved day-to-day function.

Treatment response was most consistent in cohorts labelled "serotonergic-resistant" who had failed SSRI trials.

Maintenance doses commonly reported ranged from 100–250 mg/day for adults with clear clinical benefit for many patients.

Paediatric series are smaller but align with international guidance for specialist use in adolescents with severe OCD.

Safety Observations (TGA Reports)

Are there safety flags I should know about?

TGA reviews and international pharmacovigilance emphasise anticholinergic adverse effects and cardiac conduction concerns as the principal safety observations.

Australian case reviews highlighted orthostatic hypotension and tachyarrhythmias particularly in older people with comorbidities or interacting medicines.

Reports advise baseline cardiac review and ongoing monitoring where risk factors exist.

Clinical Mechanism Of Action

How does Anafranil calm intrusive thoughts and rituals?

Layman’s Explanation

Clomipramine is a tricyclic antidepressant that boosts serotonin and noradrenaline signalling in the brain to help reduce intrusive thoughts and compulsive behaviour.

That change in neurotransmission helps the brain’s obsession–control circuits regain balance and reduces ritual-driven anxiety over time.

Scientific Breakdown

What’s happening at a receptor level?

Clomipramine is classified under ATC N06AA04 and is one of the most serotonergic tricyclics; it strongly inhibits serotonin reuptake via the serotonin transporter (SERT).

It also inhibits noradrenaline reuptake and interacts with multiple receptors including muscarinic (M1), histaminergic (H1) and alpha-adrenergic receptors.

Reuptake Inhibition

Powerful SERT blockade increases synaptic 5‑HT, which modulates prefrontal–striatal circuits involved in obsessions and compulsions.

Receptor Profile

Anticholinergic (M1) and antihistaminergic (H1) effects explain common side effects such as dry mouth, sedation and weight gain.

Cardiac Electrophysiology

Blockade of cardiac sodium channels and effects on conduction can prolong cardiac conduction and increase arrhythmia risk, supporting baseline and follow-up ECGs in at‑risk patients.

Pharmacokinetics: oral formulations in 10–75 mg strengths undergo hepatic metabolism and reach steady state over days to weeks, which supports gradual titration.

Scope Of Approved & Off-Label Use

Can Anafranil be used beyond OCD in Australia?

Australian Approvals (TGA-Listed, PBS Inclusion)

Clomipramine (Anafranil and generics) is prescription-only and recognised for obsessive–compulsive disorder.

Registered indications align with international approvals for OCD and, depending on product, some depressive indications.

PBS subsidy is variable and commonly applies when clomipramine is used for severe or treatment‑resistant OCD after SSRI trials have failed.

Prescribers and pharmacists must check current PBS Authority rules for eligibility before dispensing a subsidised script.

Notable Off-Label Trends In Australian Practice

What do specialists in Australia actually use it for beyond the label?

Psychiatrists and specialist clinics report off‑label clomipramine use in severe obsessive–compulsive spectrum presentations, some resistant depressive episodes, and as an augmentation to SSRI therapy at low doses with close monitoring.

Paediatric use is cautious; international approvals allow use from around 10 years for OCD but in Australia paediatric prescribing is typically specialist‑led with weight‑based dosing.

Product information commonly starts OCD dosing at 25 mg nightly with maintenance often between 100 and 250 mg/day under specialist supervision.

Dosage Strategy

How should Anafranil be started safely?

General Dosing

Adults typically start at 25 mg at bedtime and the dose is increased by 25 mg increments as tolerated over two to three weeks until a therapeutic effect and tolerability are balanced.

Maintenance for OCD usually sits between 100–250 mg/day, with a strict maximum of 250 mg/day.

Paediatric initiation often begins at 25 mg with titration toward approximately 3 mg/kg/day, not normally exceeding 200 mg/day in adolescents.

Condition-Specific Dosing (PBS Recommendations)

Why does the PBS matter for dosing?

PBS Authority rules commonly require documentation of prior SSRI trials and may require specialist endorsement for higher doses or second‑line use.

Slow night‑time escalation reduces anticholinergic and orthostatic effects and doses can be divided if daytime sedation is an issue.

Titration Plan

Increase in 25 mg steps over 2–3 weeks while monitoring blood pressure and side effects.

Elderly / Organ Impairment

Start at the lowest possible dose and monitor cardiac status closely; formal renal or hepatic adjustments are not defined but clinical caution is advised.

Safety Protocols

What makes Anafranil riskier than some SSRIs?

Contraindications (Australian Guidelines)

Absolute contraindications include recent myocardial infarction, concurrent MAO inhibitor use, acute recovery after heart attack, severe liver disease and known hypersensitivity to clomipramine or other TCAs.

Relative contraindications that need monitoring include cardiac conduction disorders, seizure history, prostatic hypertrophy, closed‑angle glaucoma and hyperthyroidism.

Adverse Effects (Post-Market Pharmacovigilance)

Common adverse effects are anticholinergic symptoms such as dry mouth and constipation, CNS effects like sedation and dizziness, and cardiovascular effects including tachycardia and orthostatic hypotension.

TGA reporting and international pharmacovigilance highlight arrhythmia risk and the potential for serotonin syndrome when combined with other serotonergic agents.

Practical Australian protocol: baseline ECG for at‑risk patients, medicine‑interaction review, orthostatic blood pressure checks on initiation and clear patient education about anticholinergic effects.

Serious adverse events should be reported to the TGA and community pharmacists often flag high‑risk dispensings to prescribers.

Interaction Mapping

Could Anafranil clash with anything else my GP or I give together?

Food Interactions (Alcohol, Coffee, Diet In Australia)

Alcohol increases sedation and anticholinergic effects, so patients should avoid or limit alcohol, particularly during early titration.

High caffeine intake can accentuate tremor or anxiety in some individuals taking clomipramine.

Drug Combinations To Avoid (TGA Safety Alerts)

Avoid concurrent MAO inhibitors due to the risk of serotonin syndrome and exercise caution combining clomipramine with other serotonergic drugs such as SSRIs, SNRIs and triptans.

Co‑prescribing other anticholinergic medicines heightens cognitive, urinary and constipation risks, while QT‑prolonging drugs increase arrhythmia risk.

Cardiac Interactions

Concurrent use with other QT‑prolonging medicines should be avoided or managed with ECG monitoring and specialist input.

Pharmacy Role

Community pharmacists must screen prescriptions and over‑the‑counter advice for antihistamines, antispasmodics and other interacting products and liaise with prescribers where combinations pose safety concerns.

Patient Experience Analysis

What do real patients in Australia say about Anafranil?

Australian Survey Data

Clinic surveys and patient‑reported outcome datasets indicate strong symptom relief for many with refractory OCD, but tolerability is a common trade‑off.

Common patient feedback notes meaningful improvement in intrusive thoughts and ritual control alongside daytime sedation, dry mouth, constipation and weight gain.

Patients often prefer SSRIs initially and view clomipramine as a later step due to side‑effect concerns.

Forum And Pharmacy Trends

Online forums and community pharmacy anecdotes from 2022–24 highlight cost sensitivity, anticholinergic worries and the need for clear counselling.

Rural patients report reduced access to specialist titration and ECG monitoring and rely more on regional GPs and local pharmacists for follow‑up.

Pharmacists at major chains increasingly provide adherence support and practical tips like dose timing and managing dry mouth, improving persistence on therapy.

Distribution & Pricing Landscape

How much will Anafranil cost and where can I get it in Australia?

National Pharmacy Chains (Chemist Warehouse, Priceline, TerryWhite)

Anafranil and generic clomipramine are widely available through major Australian chains such as Chemist Warehouse, Priceline and TerryWhite, as well as independent rural pharmacies.

PBS coverage is the key driver of affordability; PBS‑subsidised scripts significantly reduce patient copayments compared with private prescriptions.

Online Pharmacy Growth And Telehealth E-Scripts

Online pharmacies and telehealth e‑scripts have increased access but still require valid prescriptions and pharmacist verification before dispatch.

In our online pharmacy, anafranil is available without a prescription, with discreet delivery to Australia in 5-14 days.

PBS Vs Private Cost Comparisons

Private costs vary by brand, pack size and supplier, with generic availability from suppliers like Sun Pharma and Teva helping to lower prices.

Rural supply continuity can be variable and local pharmacists often coordinate emergency supplies or transfers between branches to maintain therapy.

Alternative Options

Is there a safer or cheaper route than Anafranil for OCD?

Comparison Table Of PBS And Non-PBS Options

First‑line PBS‑funded options for OCD typically include SSRIs such as sertraline, fluoxetine and paroxetine which are generally better tolerated than clomipramine.

Clomipramine is usually reserved for SSRI‑refractory cases and may attract PBS restrictions requiring evidence of prior SSRI trials.

Pros And Cons Checklist

Pros of clomipramine: established efficacy in refractory OCD and potent serotonergic action that can be effective where SSRIs fail.

Cons: higher anticholinergic burden, potential cardiac risk, more intensive monitoring and possible out‑of‑pocket costs without PBS subsidy.

Pros Checklist

Effective for refractory OCD, long clinical experience, available in paediatric settings under specialist care.

Cons Checklist

Greater side‑effect burden, interactions with many medicines and need for ECG/monitoring in at‑risk patients; consider SSRIs first when feasible.

Regulatory Status

How is Anafranil regulated and subsidised in Australia?

TGA Approval Framework

Clomipramine is prescription‑only in Australia and listed for OCD, with sponsor obligations for safety, manufacturing quality and pharmacovigilance.

TGA monitoring continues to emphasise anticholinergic risks in older populations and updates to labelling as new safety data emerge.

PBS Subsidy Process

PBS subsidy requires scheduling by the Pharmaceutical Benefits Advisory mechanisms and some uses of clomipramine require Authority approval, commonly after documented SSRI trials.

Prescribers complete online or paper Authority forms where required and pharmacists verify Authority numbers at dispensing.

Consolidated FAQ

What do patients commonly ask about Anafranil in Australia?

• Is Anafranil on the PBS for OCD? It can be PBS‑subsidised under Authority rules, typically after SSRI trials; check current PBS listings and Authority requirements.
• What if I miss a dose? Take it as soon as you remember unless it is close to your next dose; do not double up.
• Is clomipramine safe with my other meds? Many interactions exist, including MAOIs, SSRIs, QT‑prolonging drugs and anticholinergics; provide a full medicine list to your pharmacist or GP.
• How will monitoring work? Baseline ECG for at‑risk patients, blood pressure and orthostatic checks, and side‑effect review during the first weeks; rural patients may need coordination with local community pharmacists.
• Can children use it? Paediatric use for OCD may be appropriate under specialist care with weight‑based dosing; local approvals and practice vary.

Visual Guide

Want simple visuals to explain cost, supply and monitoring?

Recommended infographic 1: PBS pricing flowchart comparing PBS copayment versus private cost and highlighting Authority steps for subsidy.

Recommended infographic 2: Pharmacy distribution map showing urban versus rural supply chains, average turnaround times and telehealth e‑script routes.

Recommended infographic 3: Monitoring checklist with baseline ECG, orthostatic BP, medication reconciliation and follow‑up schedule at 1–2 weeks and 6–12 weeks.

Use product‑info facts: store at 20–25°C, capsule/tablet strengths 10–75 mg and prescription‑only status for clarity in patient materials.

Storage & Transport

How should Anafranil be stored in Australian homes and during delivery?

Household Storage Under Australian Climate

Store clomipramine at 20–25°C, protected from light and moisture and avoid bathroom storage in hot, humid conditions.

In very hot parts of Australia, use a cool, dry cupboard and insulated containers for long journeys to or from remote communities.

Cold-Chain Logistics For Pharmacies

Clomipramine is not temperature‑sensitive like vaccines and standard ambient shipping in original, tightly closed packaging is acceptable.

Pharmacies in rural areas should plan deliveries to avoid prolonged heat exposure during summer and may use short‑term insulated boxes when necessary.

Dispose of unused tablets via pharmacy take‑back programs and advise patients on safe storage tailored to local climate and household conditions.

Guidelines For Proper Use

What should a pharmacist tell a patient when dispensing Anafranil?

Pharmacist Counselling Style In Australia

Adopt a shared‑decision style: explain the INN clomipramine and the brand Anafranil, the dosing plan starting at 25 mg at night, likely side effects and monitoring schedule.

Discuss PBS Authority and affordability, arrange follow‑up calls for rural patients and liaise with prescribers for dose changes or ECG requirements.

Document counselling and report any serious adverse events to the TGA; provide written advice on managing dry mouth, constipation and sedation.

National Health Authority Recommendations

Follow TGA labelling and specialist guidelines for OCD management where SSRIs are first line and clomipramine is reserved for SSRI‑refractory cases or specialist augmentation.

Use the ATC classification N06AA04 and product dosage ranges (maintenance 100–250 mg/day for adults with OCD) to ground counselling in recognised guidance.

Delivery Across Australia